ARCHIVES

GSK’s Votrient Approved For Advanced Kidney Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 10 | October 30, 2009

Download PDF Visit The Full Archive

Related Articles

Philadelphia Group Begins BMT Trial for Breast Cancer

April 5, 1991

Analysis Reveals CAIX Subgroup Responsive to Rencarex Therapy

June 28, 2013

M. D. Anderson Buys Record System For In-Patient Services From Atlanta Firm.

May 4, 2001

Strategic Plan Identifies Goal; To Be The Authoritative Source For Cancer Information

May 21, 1999

Immunotherapy Demonstrates Disease Control in Phase II Study

September 28, 2012

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

October 14, 2005